FR2150559A1 - Australia antigen purification - for preparation of purified suspensions - Google Patents

Australia antigen purification - for preparation of purified suspensions

Info

Publication number
FR2150559A1
FR2150559A1 FR7120905A FR7120905A FR2150559A1 FR 2150559 A1 FR2150559 A1 FR 2150559A1 FR 7120905 A FR7120905 A FR 7120905A FR 7120905 A FR7120905 A FR 7120905A FR 2150559 A1 FR2150559 A1 FR 2150559A1
Authority
FR
France
Prior art keywords
preparation
suspensions
australia antigen
purified
antigen purification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7120905A
Other languages
English (en)
French (fr)
Other versions
FR2150559B1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Merieux SA
Original Assignee
Institut Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Merieux SA filed Critical Institut Merieux SA
Priority to FR7120905A priority Critical patent/FR2150559A1/fr
Publication of FR2150559A1 publication Critical patent/FR2150559A1/fr
Application granted granted Critical
Publication of FR2150559B1 publication Critical patent/FR2150559B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
FR7120905A 1971-06-09 1971-06-09 Australia antigen purification - for preparation of purified suspensions Granted FR2150559A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7120905A FR2150559A1 (en) 1971-06-09 1971-06-09 Australia antigen purification - for preparation of purified suspensions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7120905A FR2150559A1 (en) 1971-06-09 1971-06-09 Australia antigen purification - for preparation of purified suspensions

Publications (2)

Publication Number Publication Date
FR2150559A1 true FR2150559A1 (en) 1973-04-13
FR2150559B1 FR2150559B1 (enrdf_load_stackoverflow) 1975-01-17

Family

ID=9078354

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7120905A Granted FR2150559A1 (en) 1971-06-09 1971-06-09 Australia antigen purification - for preparation of purified suspensions

Country Status (1)

Country Link
FR (1) FR2150559A1 (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus
FR2488510A1 (fr) * 1980-08-15 1982-02-19 Merck & Co Inc Procede de separation de l'antigene de surface de l'hepatite b

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470795A1 (fr) * 1979-12-07 1981-06-12 Pasteur Institut Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus
FR2488510A1 (fr) * 1980-08-15 1982-02-19 Merck & Co Inc Procede de separation de l'antigene de surface de l'hepatite b

Also Published As

Publication number Publication date
FR2150559B1 (enrdf_load_stackoverflow) 1975-01-17

Similar Documents

Publication Publication Date Title
CH555358A (de) Verfahren zur herstellung von 2-(thienyl-3'-amino)-1,3diazacycloalkenen-(2).
IT954175B (it) Perfezionamento nei procedimenti per la separazione di miscele di gas
DK606287A (da) Hybridomacellelinier, der producerer monoklonale antistoffer, som reagerer med mucinepitoper
IL38833A0 (en) Separation apparatus employing semipermeable membranes especially useful for ultrafiltration
DE3483252D1 (de) Verfahren zur induktion von antitumorimmunozyten, verfahren zur herstellung von antitumorimmunozyten und durch das verfahren hergestellte antitumorimmunozyten.
DK60876A (da) Diagnostisk middel til konstatering af hepatitis b overfladeantigen i menneskeblod samt fremgangsmade til fremstilling af midlet, provningsfremgangsmade under anvendelse af midlet og provningsset til brug ved provningsfremgangsmaden
FR2150559A1 (en) Australia antigen purification - for preparation of purified suspensions
AT309466B (de) Verfahren zur Herstellung von Benzylphosphonaten
BE746629A (fr) Procede pour la formation de membranes semi-permeables pour dessalementd'eaux saumatres et marines, par hyperfiltration, et membranes produites par le susdit procede
CH555793A (de) Verfahren zur herstellung von gegebenenfalls substituierten perfluoralkyljodid-olefin- bzw.-cycloolefin-1:1-addukten.
NL163245C (nl) Werkwijze ter bereiding van bestendige emulsies van verknoopbare, sterk viskeuze organopolysiloxanen.
AT317428B (de) Verfahren zur Herstellung von Cephalosporin C
AT316872B (de) Verfahren zur Herstellung von wässerigen Suspensionen oder Pasten von faserigen, in sich vernetzten Teilchen
AT308294B (de) Verfahren zur Herstellung des neuen 6,6-Difluor-11α, 16α, 17α-trihydroxy-4-pregnen-3,20-dions
CH540302A (de) Verfahren zur Herstellung von Vinylhalogenidhomopolymeren mit verbesserten Verarbeitungseigenschaften
CH550800A (de) Verfahren zur herstellung von 1-alkyl-1,8-naphthyridinverbindungen.
ATA952372A (de) Verfahren zur herstellung von 4-chlor-2,5-dimethoxy-anilin
CH550272A (de) Zur trennung von elektroden geeignete nonwoven-schicht.
AT314489B (de) Verfahren zur Herstellung von Oxoverbindungen
EP0040020A3 (en) Human reverse transcriptase enzyme, method for its purification, and its use in the detection of breast cancer
AT321466B (de) Verfahren zur Herstellung eines intravenös verabreichbaren, modifizierten Immunserumglobulins
SU1740A1 (ru) Способ разделени углистых частиц при помощи пенистого обогащени
FR470886A (fr) Procédés et appareils pour l'absorption ou l'introduction de solutions alimentaires, médicamenteuses ou analogues
ATA471972A (de) Verfahren zur herstellung von 16beta-methyl-17alpha-hydroxy-1,4,9,(11)-pregnatrien-3,20-dion (i)
CH547796A (de) Verfahren zur herstellung von 1,3-dioxolanen und -dioxanen.

Legal Events

Date Code Title Description
ST Notification of lapse